Skip to content

pharmaceuticals.co.nz

Drugs, medicines and medical news
Main navigation

Category: Parkinson’s disease

Roche partners with Cardiff researchers to uncover new research into dementia

Affecting 55 million people globally, dementia impairs the ability to remember, think or make decisions

March 14, 2024 Alzheimer's disease, Cardiff University Brain Research Imaging Centre, Dementia, neurodegenerative conditions, News, Parkinson's disease, roche

AbbVie’s Produodopa approved by SMC to treat Parkinson’s disease patients in Scotland

The progressive neurological disorder affects approximately 12,400 people in Scotland

March 13, 2024 AbbVie, foslevodopa-foscarbidopa, Neurological disorders, News, Parkinson's disease, Produodopa, Scottish Medicines Consortium

Predict-PD study to identify those at high risk of PD before symptoms appear

The study aims to improve the representation of ethnic diversity within Parkinson’s research

February 19, 2024 News, Parkinson's disease, Parkinson’s UK, Queen Mary University, uMed, University College London

Study reveals SARS-CoV-2 can infect dopamine neurons causing senescence

Dopamine neuron senescence is a hallmark of Parkinson’s disease

February 2, 2024 Columbia University Vagelos College of Physicians and Surgeons, COVID-19, dopamine neurons, long covid, Memorial Sloan Kettering Cancer Center, News, Parkinson's disease, SARS-CoV-2, senescence, Weill Cornell Medicine

Posts navigation

Posts pagination

« Previous 1 2
Next »
Proudly powered by WordPress | Theme: Hive Lite by Pixelgrade.
Footer navigation
  • Privacy Policy